AU7673900A - Glycosides and orthoester glycosides of raloxifene and analogues and the use thereof - Google Patents

Glycosides and orthoester glycosides of raloxifene and analogues and the use thereof

Info

Publication number
AU7673900A
AU7673900A AU76739/00A AU7673900A AU7673900A AU 7673900 A AU7673900 A AU 7673900A AU 76739/00 A AU76739/00 A AU 76739/00A AU 7673900 A AU7673900 A AU 7673900A AU 7673900 A AU7673900 A AU 7673900A
Authority
AU
Australia
Prior art keywords
glycosides
raloxifene
analogues
orthoester
orthoester glycosides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU76739/00A
Inventor
Michael Francis Holick
Halasya Ramanathan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Strakan Ltd
Original Assignee
Kyowa Kirin International PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Kirin International PLC filed Critical Kyowa Kirin International PLC
Publication of AU7673900A publication Critical patent/AU7673900A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU76739/00A 1999-10-08 2000-10-06 Glycosides and orthoester glycosides of raloxifene and analogues and the use thereof Abandoned AU7673900A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US15814199P 1999-10-08 1999-10-08
US60158141 1999-10-08
US23157300P 2000-09-11 2000-09-11
US60231573 2000-09-11
PCT/GB2000/003864 WO2001027129A1 (en) 1999-10-08 2000-10-06 Glycosides and orthoester glycosides of raloxifene and analogues and the use thereof

Publications (1)

Publication Number Publication Date
AU7673900A true AU7673900A (en) 2001-04-23

Family

ID=26854778

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76739/00A Abandoned AU7673900A (en) 1999-10-08 2000-10-06 Glycosides and orthoester glycosides of raloxifene and analogues and the use thereof

Country Status (2)

Country Link
AU (1) AU7673900A (en)
WO (1) WO2001027129A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7425565B2 (en) 2002-05-09 2008-09-16 Cedars-Sinai Medical Center Use of benzothiopenes to treat and prevent prostate cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69331833T2 (en) * 1992-12-29 2002-11-14 Michael F. Holick USE OF VITAMIN D-GLYCOSIDES FOR TREATING OR PREVENTING OSTEOPOROSIS
US6723739B1 (en) * 1994-05-20 2004-04-20 Eli Lilly And Company Glucopyranoside benzothiophenes
US5612317A (en) * 1994-08-04 1997-03-18 Holick; Michael F. Method for delivering estrogen
US5563054A (en) * 1995-03-31 1996-10-08 Eli Lilly And Company Process for preparation of benzo[B]thiophene glucuronides
US6090843A (en) * 1997-08-11 2000-07-18 Eli Lilly And Company Benzothiophenes compounds which have useful pharmaceutical activity

Also Published As

Publication number Publication date
WO2001027129A1 (en) 2001-04-19

Similar Documents

Publication Publication Date Title
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
AU1101699A (en) Therapeutic pillow
AU5970699A (en) Use
AU5565099A (en) Pharmaceutical compositions and methods for use
AU8967998A (en) Antibiotic-ligand conjugates and methods of use thereof
AU5161399A (en) N-benzocycloalkyl-amide derivatives and their use as medicaments
AU1403501A (en) Novel composition and use
HUP0103636A3 (en) 2-methyl-thieno-benzodiazepine formulation and its use
AU2841801A (en) Triazolotriazinones and the use thereof
AU7853700A (en) Foams and compositions containing these foams
AU5762099A (en) The preparation of (n)-substituted-hydroxycycloalkylamine derivatives
AU1889599A (en) Disintegrating agent
AU6351199A (en) Pectins and the preparation thereof
AU1152601A (en) Compositions and their use
AUPP584198A0 (en) New use
AU4923900A (en) Glass keyboard and use thereof
AU7410900A (en) Alginate preparation and use of the same
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
AU4839100A (en) Methods of using and compositions comprising n-desmethylzolpidem
AU8333998A (en) New use of nociceptin
AU7673900A (en) Glycosides and orthoester glycosides of raloxifene and analogues and the use thereof
AU2880699A (en) Pharmaceutical compositions and methods for use
AUPO982097A0 (en) Methods and compositions for use therein
AU2669201A (en) Taccalonolides and their use
AU2227999A (en) Human ependymin

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase